Around 20% of the world's population suffers from the Allergic Conjunctivitis Market. Seasonal allergic conjunctivitis affects about 98 percent of the population, while perennial allergic conjunctivitis affects the remaining 2%. The Allergic Conjunctivitis Market is dominated by North America, with the greatest market share, followed by Europe and Asia-Pacific. The rise in the usage of chemicals and pollutants as a result of urbanization, industrialization, and climate change has increased the occurrence of allergic conjunctivitis. One of the factors boosting the market is increased awareness of allergic conjunctivitis and its accompanying medical treatment.
What is Allergic Conjunctivitis and What Causes It?
Allergic Conjunctivitis Market is an inflammation of the conjunctiva caused by an allergic reaction to allergens such as pollen, mold spores, dust mites, or animal fur. The conjunctiva, a membrane that lines the inside of the eyeball, is prone to irritation from allergens. Allergic conjunctivitis is the body's reaction to potentially dangerous chemicals. Seasonal allergic conjunctivitis, permanent allergic conjunctivitis, large papillary conjunctivitis, vernal keratoconjunctivitis, and atopic keratoconjunctivitis are all examples of allergic conjunctivitis. Red, itchy, watery, and burning eyes are some of the symptoms of allergic conjunctivitis. Oral medicines, ocular drops, and immunotherapy can all be used to treat allergic conjunctivitis.
Read more @ https://cmiinfopiece.blogspot.com/2021/12/the-global-allergic-conjunctivitis.html
Source Link:https://bit.ly/3dSevCj
